Lee You Bin, Lee Dong-Hyun, Kim Youn Chul, Bhang Suk Ho
School of Chemical Engineering, Sungkyunkwan University (SKKU), 2066 Seobu-Ro, Jangan-Gu, Suwon, Gyeonggi-Do, 16419, Republic of Korea.
Tissue Eng Regen Med. 2024 Nov 23. doi: 10.1007/s13770-024-00681-x.
Polylactic acid (PLA) is extensively used in the medical and cosmetic industries for skin regeneration and as a dermal filler due to its biocompatibility and biodegradability. However, the effectiveness of PLA as a cosmetic filler is limited by its slow degradation rate and poor cell attachment properties. Recent studies have focused on enhancing the performance of PLA by combining it with other materials. This study aimed to evaluate the performance of carboxymethyl cellulose (CMC), known for its high biocompatibility, in comparison with the widely used hyaluronic acid (HA).
Two types of PLA-based particles, HA-PLA and CMC-PLA were synthesized by combining PLA with HA and CMC, respectively. After characterizing the particles, we evaluated cell adhesion and viability using human dermal fibroblasts and analyzed gene and protein expression related to cell attachment and angiogenic paracrine factors.
The CMC-PLA particles maintained a more uniform size distribution than the HA-PLA particles and exhibited superior cell adhesion properties. Cells attached on the CMC-PLA particles showed enhanced secretion of angiogenic paracrine factors, suggesting a potential improvement in therapeutic efficacy.
CMC-PLA particles demonstrated superior cell adhesion and secretion capabilities compared with HA-PLA particles, indicating their potential for application in skin regeneration and tissue recovery. Further research, including in vivo studies, is required to fully explore and validate the therapeutic potential of CMC-PLA particles.
聚乳酸(PLA)因其生物相容性和生物降解性,在医疗和美容行业被广泛用于皮肤再生及作为真皮填充剂。然而,PLA作为美容填充剂的有效性受到其缓慢降解速率和较差细胞附着特性的限制。最近的研究集中于通过将PLA与其他材料结合来提高其性能。本研究旨在评估以高生物相容性著称的羧甲基纤维素(CMC)与广泛使用的透明质酸(HA)相比的性能。
分别通过将PLA与HA和CMC结合,合成了两种基于PLA的颗粒,即HA-PLA和CMC-PLA。在对颗粒进行表征后,我们使用人皮肤成纤维细胞评估细胞黏附及活力,并分析与细胞附着和血管生成旁分泌因子相关的基因和蛋白质表达。
与HA-PLA颗粒相比,CMC-PLA颗粒保持了更均匀的尺寸分布,并表现出优异的细胞黏附特性。附着在CMC-PLA颗粒上的细胞显示出血管生成旁分泌因子分泌增强,提示治疗效果可能得到改善。
与HA-PLA颗粒相比,CMC-PLA颗粒表现出优异的细胞黏附及分泌能力,表明其在皮肤再生和组织修复中的应用潜力。需要进一步研究,包括体内研究,以充分探索和验证CMC-PLA颗粒的治疗潜力。